Kevin N. Litchfield
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Clonal LIMD1 loss drives PD-L1 immune evasion via ARIH1-dependent ubiquitination in lung cancer.
Journal: Life science alliance
Published: June 11, 2026
The rise of AlphaFold in drug design.
Journal: Progress in medicinal chemistry
Published: October 23, 2025
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome.
Journal: Immunity
Published: August 12, 2025
Plasma signals of lung tumor promotion for molecular cancer prevention.
Journal: Cell
Published: July 04, 2025
Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing.
Journal: Molecular cancer research : MCR
Published: June 10, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.
Journal: Immunity
Published: May 30, 2025
Meta-analysis of Germline Whole-exome Sequencing in 1435 Cases of Testicular Germ Cell Tumour to Evaluate Disruptive Mutations Under Dominant, Recessive, and X-linked Inheritance Models.
Journal: European urology open science
Published: January 30, 2025
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation.
Journal: Nature machine intelligence
Published: November 21, 2024
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2024
Translation dysregulation in cancer as a source for targetable antigens.
Journal: Cancer cell
Published: June 19, 2024
Last Updated: 09/26/2026